evidencegaps
Primary study · included by 1 review

Mesenchymal stem cell transplantation alleviates Sjögren's syndrome symptoms by modulating Tim-3 expression

Sun 2022 · Sun Tian, Liu Shanshan, Yang Guangxia, et al. · International Immunopharmacology · 2022

Included by

The Efficacy of Mesenchymal Stem Cell-Based Therapy for Sjögren's Syndrome: A Systematic Review and Meta-Analysis of Preclinical Studies.
Non-Cochrane · intervention · 2026 · cited as Sun 2022 · Table; Reference list; Supplementary Data 2

The review does not say which of its outcomes this study informs.

1 including review in total.